Cargando…
A case report of apatinib in treating osteosarcoma with pulmonary metastases
RATIONALE: Osteosarcoma is the most common malignant bone tumor in children and adolescents. Pulmonary metastases lead to a significantly increased risk of death. Apatinib, a new potent oral small-molecule tyrosine kinase inhibitor targeting the intracellular domain of vascular endothelial growth fa...
Autores principales: | Zhou, Yong, Zhang, Wengeng, Tang, Fan, Luo, Yi, Min, Li, Zhang, Wenli, Shi, Rui, Duan, Hong, Tu, Chongqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403083/ https://www.ncbi.nlm.nih.gov/pubmed/28403086 http://dx.doi.org/10.1097/MD.0000000000006578 |
Ejemplares similares
-
Remarkable response to anti-PD1 immunotherapy in refractory metastatic high-grade myxofibrosarcoma patient: A case report
por: Luo, Yi, et al.
Publicado: (2021) -
Advanced alveolar soft part sarcoma responds to apatinib
por: Zhou, Yong, et al.
Publicado: (2017) -
Classic Hodgkin lymphoma in pelvis: A case report highlights diagnosis and treatment challenges
por: Tang, Fan, et al.
Publicado: (2017) -
The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature
por: Ding, Lin, et al.
Publicado: (2016) -
Anaplastic lymphoma kinase-negative pulmonary inflammatory myofibroblastic tumor with multiple metastases and its treatment by Apatinib: A case report
por: Liu, Qiuxia, et al.
Publicado: (2019)